<--- Back to Details
First PageDocument Content
Chemistry / Quality-adjusted life year / Systolic hypertension / Antihypertensive drug / Cost–utility analysis / National Institute for Health and Clinical Excellence / Eprosartan / Hypertension / Nitrendipine / Medicine / Health / Health economics
Date: 2010-09-14 05:17:08
Chemistry
Quality-adjusted life year
Systolic hypertension
Antihypertensive drug
Cost–utility analysis
National Institute for Health and Clinical Excellence
Eprosartan
Hypertension
Nitrendipine
Medicine
Health
Health economics

Microsoft Word - 8150_submit_Gradl.doc

Add to Reading List

Source URL: cardio.by

Download Document from Source Website

File Size: 469,80 KB

Share Document on Facebook

Similar Documents

Chemistry / Quality-adjusted life year / Systolic hypertension / Antihypertensive drug / Cost–utility analysis / National Institute for Health and Clinical Excellence / Eprosartan / Hypertension / Nitrendipine / Medicine / Health / Health economics

Microsoft Word - 8150_submit_Gradl.doc

DocID: K5ek - View Document

Calcium channel blockers / Dihydropyridines / Nitrobenzenes / Hypertension / Antihypertensive drug / Blood pressure / Hypertensive emergency / Nitrendipine / Nifedipine / Chemistry / Medicine / Organic chemistry

Acute and Short-Term Effects of a New Calcium Antagonist in Hypertension JAMES F. BURRIS, M.D., ALDO V. NOTARGIACOMO, B.S., VASILIOS PAPADEMETRIOU, M.D., AND EDWARD D. FREIS, M.D.

DocID: vOXw - View Document

Organic chemistry / Cilnidipine / Nicardipine / Nifedipine / Antihypertensive drug / Amlodipine / Nitrendipine / Chemistry / Calcium channel blockers / Dihydropyridines

Cardiovascular Drug Reviews Vol. 17, No. 4, pp. 341–357 © 1999 Neva Press, Branford, Connecticut

DocID: 4lME - View Document